Dr. Noor Haddad is a physician with the Boreas Station Medical Service and first author of the 2179 mirror-fold encephalopathy paper — the index case, retrospective series, prevalence estimate, and candidate clearance agent MFB-1 that identified the first human disease caused by templating across the L/D-chirality barrier. The paper’s index case presented at the station in March 2176.

Twelve days after publication, in Boreas Broadcasting Network coverage of 16 December 2179, Haddad said the station clinic had been receiving requests since publication and had no test to offer — the mirror-selective assay, in the station laboratory and one Dome 4 laboratory, “is not a clinical test. It has not been validated for screening” — and confirmed the station was not recommending imaging for asymptomatic recipients: “We found this disease because a patient had symptoms. We cannot find it in people who do not.” Asked what the station should do while it waits, Haddad’s answer was not clinical: “The containment programme is funded and the clinic is funded. Whatever the clearance agent becomes, it will not be funded. It will be licensed. That is the part of this I am least able to help with.”

Figure

Evidence figure for the mirror-fold encephalopathy paper. Top left: the retrospective series, one dot per case — 58 cases, 17 confirmed by tissue or mirror-selective assay and 41 suspected on clinical and imaging grounds. Exposure record across the same 58: 34 with a documented course of the 2130 class, 19 with no record, 5 incomplete; eleven of the 19 unexposed worked in hydroponic, food-processing, or chemical-synthesis occupations. The archive reanalysis: 214 cases of undetermined proteinopathy reanalysed, 19 positive, the earliest from 2151; seven of the nineteen date from 2151–2158 and were read at the time as TIGR-Tas treatment failures. Median latency from last documented exposure to first symptom is 26 years, range 18–44; median age at presentation is 71. Right, the prevalence estimate: 310,000 documented recipients form the floor, 1,240 living recipients were screened, and 14 were positive — 1.13 percent, with an upper rate of 3.6 percent across assay thresholds. Applied to the floor that gives 3,400–11,200 prevalent infections, the large majority presymptomatic, and at a 26-year median latency the caseload is expected to rise for a further four decades. The archive is biased toward fatal cases.

Figure from Haddad et al. — Mirror-Fold Encephalopathy (2179).

Sources